🇺🇸 FDA
Patent

US 11833157

Precipitation resistant small molecule drug formulations

granted A61KA61K31/197A61K31/4045

Quick answer

US patent 11833157 (Precipitation resistant small molecule drug formulations) held by XERIS PHARMACEUTICALS, INC. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XERIS PHARMACEUTICALS, INC.
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/197, A61K31/4045, A61K31/5513, A61K47/14